Muscle: an independent contributor to the neuromuscular spinal muscular atrophy disease phenotype
Open Access
- 22 September 2023
- journal article
- review article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 8 (18)
Abstract
Spinal muscular atrophy (SMA) is a pediatric-onset neuromuscular disorder caused by insufficient survival motor neuron (SMN) protein. SMN restorative therapies are now approved for the treatment of SMA; however, they are not curative, likely due to a combination of imperfect treatment timing, inadequate SMN augmentation, and failure to optimally target relevant organs. Here, we consider the implications of imperfect treatment administration, focusing specifically on outcomes for skeletal muscle. We examine the evidence that muscle plays a contributing role in driving neuromuscular dysfunction in SMA. Next, we discuss how SMN might regulate the health of myofibers and their progenitors. Finally, we speculate on therapeutic outcomes of failing to raise muscle SMN to healthful levels and present strategies to restore function to this tissue to ensure better treatment results.Keywords
This publication has 87 references indexed in Scilit:
- Satellite cell senescence underlies myopathy in a mouse model of limb-girdle muscular dystrophy 2HJournal of Clinical Investigation, 2012
- The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trialJournal of Cachexia, Sarcopenia and Muscle, 2011
- Short Telomeres and Stem Cell Exhaustion Model Duchenne Muscular Dystrophy in mdx/mTR MiceCell, 2010
- Wnt7a Activates the Planar Cell Polarity Pathway to Drive the Symmetric Expansion of Satellite Stem CellsCell Stem Cell, 2009
- Inhibition of myostatin does not ameliorate disease features of severe spinal muscular atrophy miceHuman Molecular Genetics, 2009
- Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophyHuman Molecular Genetics, 2008
- The TWEAK–Fn14 cytokine–receptor axis: discovery, biology and therapeutic targetingNature Reviews Drug Discovery, 2008
- Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effectHuman Molecular Genetics, 2008
- Asymmetric Self-Renewal and Commitment of Satellite Stem Cells in MuscleCell, 2007
- A Drosophila melanogaster model of spinal muscular atrophy reveals a function for SMN in striated muscleJournal of Cell Biology, 2007